{"url_path":"/sec/cme/8-k/2026-06-17/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1156375/0001193125-26-273442-index.html","accession_number":"0001193125-26-273442","cik":"0001156375","ticker":"CME","issuer_name":"CME GROUP INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1156375/0001193125-26-273442-index.html","primary_entity_key":"0001156375","primary_entity_name":"CME GROUP INC."},"word_count":127,"has_tables":true,"body_markdown":"Item 7.01\n\nRegulation FD Disclosure.\n\nOn June 17, 2026, the Company issued a press release relating to the Leadership Transition. A copy of the press release is furnished with this report as Exhibit 99.1 and is incorporated by reference in this Item 7.01.\n\nThe information furnished under Item 7.01 of this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information furnished under Item 7.01 of this report shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing."}